BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia

Leukemia

Volumn 16, Issue 8, 2002, Pages 1443-1447

  Steinbach, D ^a   Sell, W ^a   Voigt, A ^a   Hermann, J ^a   Zintl, F ^a   Sauerbrey, A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

BCRP; Childhood AML; Multidrug resistance; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; DAUNORUBICIN; DOXORUBICIN; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PLACENTA PROTEIN; TOPOTECAN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036052296     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402541     Document Type: Article

References (22)

1. Idarubicin improves blast cell clearance during induction therapy in children with AML: Results of study AML-BFM 93
2. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: Results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party
3. Novel mechanisms of drug resistance in leukemia
4. Frequency and clinical significance of the expression of the multi-drug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: A Southwest Oncology Group Study
5. P-glycoprotein expression on acute myeloid leukaemia blast cells at diagnosis predicts response to chemotherapy and survival
6. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML)
7. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry
8. Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: A report from the Childrens Cancer Group
9. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia
10. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia
11. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome
12. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL)
13. Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
14. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane
15. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
16. A multidrug resistance transporter from human MCF-7 breast cancer cells
17. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
18. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues
19. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
20. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia
21. Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87
22. Risk group definition in children with acute myeloid leukemia by calculating individual risk factors on the basis of a multivariate stepwise Cox regression analysis